Manidón

Verapamil, the active ingredient in Manidón, is a calcium channel blocker presented as an oral tablet for systemic use. It is employed to lower high blood pressure, relieve chest pain from angina, and manage certain cardiac rhythm disorders in adult patients. The medication works by relaxing blood vessels and reducing the heart’s workload.

GNH USA supplies Manidón as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Verapamil is used to treat cardiovascular conditions that involve elevated pressure or abnormal heart rhythms.

Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. Angina pectoris: decreases myocardial oxygen demand and alleviates chest pain during exertion. Cardiac arrhythmias: slows atrioventricular nodal conduction to control supraventricular tachycardia and other rhythm disturbances.

Common Side Effects: - Headache - Dizziness - Constipation - Flushing

Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Heart block or AV‑node conduction disturbances - Allergic skin reactions such as rash or urticaria

Before initiating therapy, consider the following precautions: - Monitor blood pressure regularly: ensure values remain within target range. - Assess cardiac function: evaluate for existing heart block or severe heart failure. - Use caution in patients with hepatic impairment: dose adjustments may be required. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Adjust concomitant diuretic therapy: watch for electrolyte imbalances. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Verapamil can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Beta‑blockers: may cause excessive bradycardia. - Digoxin: increased serum levels and risk of toxicity. - Diltiazem: additive AV‑node blockade. - Strong CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): raise verapamil concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: monitor potassium and fluid status. - Other antihypertensives: additive blood‑pressure lowering effect. - Statins metabolized by CYP3A4 (e.g., simvastatin): increased risk of statin‑related muscle toxicity.